NFL Biosciences SA

Paris Stock Exchange ALNFL.PA

NFL Biosciences SA Free Cash Flow Per Share for the year ending December 31, 2023

NFL Biosciences SA Free Cash Flow Per Share is NA for the year ending December 31, 2023. Free cash flow per share is the free cash flow generated per share. Indicates investment potential based on cash flow generation.
Key data
Date Free Cash Flow Per Share Return on Assets (ROA) Return on Equity (ROE) Return on Capital Employed (ROCE)
Market news
SV Wall Street
Paris Stock Exchange: ALNFL.PA

NFL Biosciences SA

CEO Dr. Ignacio Faus M.B.A., Ph.D.
IPO Date July 5, 2021
Location France
Headquarters 199 Rue Helene Boucher
Employees 4
Sector Health Care
Industries
Biotechnology Pharmaceuticals Tobacco
Description

NFL Biosciences SA, a biotechnology company, develops natural addiction withdrawal solutions for smokers. Its natural drug candidate in pipeline to cure tobacco addiction include NFL-101, a tobacco extract that is in Phase III clinical trial targeting smoking addiction; NFL-201, a cannabis and tobacco extract, which is in preclinical stage; and NFL-301, a botanical extract (traditional Chinese medicine) that is in preclinical stage. The company was incorporated in 2006 and is based in Castelnau-le-Lez, France.

Similar companies

ABNX.PA

ABIONYX Pharma SA

USD 1.28

-1.09%

StockViz Staff

January 31, 2025

Any question? Send us an email